A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    13 August 2022

    • curprev 08:4908:49, 13 August 2022‎ 187.21.138.9 talk‎ 551 bytes +551‎ Created page with "== Target Article == A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects; S Azarbar, A Salardini, N Dahdah, J Lazewatskyae; 2015; doi_citing_unknown == Retraction == Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m ; N Pérez Baliño V Sporn L L Holman A Sosa Liprandi O Masoli A Mitta L Camin S Castiglia K McK; 01/01/1987..."
Retrieved from "https://wikicitingretracted.org/index.php?title=A_phase_I-II,_open-label,_multicenter_trial_to_determine_the_dosimetry_and_safety_of_99mTc-Sestamibi_in_pediatric_subjects"